Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aslihan Avanoglu Guler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Rheumatology, Ankara Etlik City Hospital, 06010 Ankara, Turkey. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Calcinosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dystrophic calcinosis, which is the accumulation of insoluble calcified crystalline materials within tissues with normal circulating calcium and phosphorus levels, is a frequent finding in systemic sclerosis (SSc) and represents a major burden for patients. In SSc, calcinosis poses significant challenges in management due to the associated risk of severe complications such as infection, ulceration, pain, reduction in functional capacity and quality of life, and lack of standardized treatment choices. The exact pathogenesis of calcinosis is still unknown. There are multifaceted factors contributing to calcinosis development, including osteogenic differentiation of cells, imbalance between promoter and inhibitors of mineralization, local disturbance in calcium and phosphate levels, and extracellular matrix as a template for mineralization. Several pathophysiological changes observed in SSc such as ischemia, exacerbated production of excessive reactive oxygen species, inflammation, production of inflammatory cytokines, acroosteolysis, and increased extracellular matrix production may promote the development of calcinosis in SSc. Furthermore, mitochondrial dynamics, particularly fission function through the activity of dynamin-related protein-1, may have an effect on the dystrophic calcinosis process. In-depth investigations of cellular mechanisms and microenvironmental influences can offer valuable insights into the complex pathogenesis of calcinosis in SSc, providing potential targeting pathways for calcinosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Rheumatology, Ankara Etlik City Hospital, 06010 Ankara, Turkey.
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, 20132 Milan, Italy.
ORCID-Profile: Giacomo De Luca, Corrado Campochiaro
Zitieren
APA
Avanoglu Guler, A., De Luca, G., Dagna, L., Matucci-Cerinic, M., & Campochiaro, C. (2024). Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011257
Vancouver
Avanoglu Guler A, De Luca G, Dagna L, Matucci-Cerinic M, Campochiaro C. Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011257
BibTeX
@article{AvanogluGuler2024,
author = {Avanoglu Guler, Aslihan and De Luca, Giacomo and Dagna, Lorenzo and Matucci-Cerinic, Marco and Campochiaro, Corrado},
title = {Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011257}
}
EUVIMED